Home LiteratureArticle Details
PMID: 2263604 Published · ppublish English Case Reports Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Primary combined immunodeficiency resulting from defective transcription of multiple T-cell lymphokine genes.

Chatila T, Castigli E, Pahwa R, Pahwa S, Chirmule N, Oyaizu N, Good RA, Geha RS

Abstract

The circulating T lymphocytes of a female child with recurrent opportunistic infections were normal in number and phenotype but exhibited poor proliferation and decreased synthesis of the T-cell growth factor interleukin (IL) 2 in response to mitogens. Recombinant IL-2 fully restored the proliferative responses of her T cells, suggesting that her poor immune function was related to IL-2 deficiency. Northern blot analysis of total cellular RNA from the patient's T cells revealed markedly decreased levels of IL-2 mRNA of normal size. In addition, mRNA levels of other lymphokines selectively expressed by T cells, which include IL-3, IL-4, and IL-5, were either severely depressed or absent. The levels of interferon gamma mRNA were moderately decreased, while those of granulocyte-macrophage colony stimulating factor, a lymphokine the production of which is not restricted to T cells, were unaffected. The decreased level of lymphokine mRNA in the patient's T lymphocytes was not from enhanced catabolism but resulted from a diminution in the transcription rate of the affected lymphokine genes. Normal transduction via the T-cell receptor/CD3 complex of biochemical signals necessary for the initiation of lymphokine gene transcription indicated that the defect was distal to the membrane signal-transducing apparatus. The defect is hypothesized to involve a T-cell-specific trans-acting regulatory factor required for transcription of the affected lymphokine genes.

MeSH Terms
Antibodies, Monoclonal Cells, Cultured Child, Preschool Cytokines/biosynthesis Female Fluorescent Antibody Technique Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis,genetics Humans Immunologic Deficiency Syndromes/genetics,immunology Interleukins/biosynthesis,genetics Lymphokines/genetics RNA, Messenger/genetics,isolation & purification T-Lymphocytes/immunology Transcription, Genetic
Chemicals
Antibodies, Monoclonal Cytokines Interleukins Lymphokines RNA, Messenger Granulocyte-Macrophage Colony-Stimulating Factor
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Chatila T
Division of Immunology, Children's Hospital, Boston, MA.
Castigli E
Pahwa R
Pahwa S
Chirmule N
Oyaizu N
Good R A
Geha R S
References (16)
16 references, click to expand
  1. Functional and morphologic characterization of human T cells continuously grown in vitro.
    J Immunol. 1977 Jul;119(1):131-8 PMID: 141483
  2. Severe combined immunodeficiency due to a specific defect in the production of interleukin-2.
    N Engl J Med. 1990 Jun 14;322(24):1718-23 PMID: 2342538
  3. Sequential expression of genes involved in human T lymphocyte growth and differentiation.
    J Exp Med. 1985 Jun 1;161(6):1593-8 PMID: 2989408
  4. The role of the T3/antigen receptor complex in T-cell activation.
    Annu Rev Immunol. 1986;4:593-619 PMID: 2939858
  5. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.
    Cell. 1986 Aug 29;46(5):659-67 PMID: 3488815
  6. Lymphokines.
    N Engl J Med. 1987 Oct 8;317(15):940-5 PMID: 2442611
  7. Phosphorylation of T cell membrane proteins by activators of protein kinase C.
    J Immunol. 1988 Jun 15;140(12):4308-14 PMID: 3259610
  8. Contingent genetic regulatory events in T lymphocyte activation.
    Science. 1989 Jan 20;243(4889):355-61 PMID: 2783497
  9. An immunodeficiency characterized by defective signal transduction in T lymphocytes.
    N Engl J Med. 1989 Mar 16;320(11):696-702 PMID: 2784191
  10. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway.
    Science. 1989 Apr 21;244(4902):339-43 PMID: 2540528
  11. Mechanism of mononuclear cell activation by an anti-CD43 (sialophorin) agonistic antibody.
    J Immunol. 1989 Jun 15;142(12):4194-200 PMID: 2542404
  12. Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.
    Proc Natl Acad Sci U S A. 1989 Jul;86(13):5069-73 PMID: 2787027
  13. Cyclosporine.
    N Engl J Med. 1989 Dec 21;321(25):1725-38 PMID: 2687689
  14. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation.
    Science. 1989 Dec 22;246(4937):1617-20 PMID: 2595372
  15. Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells.
    J Exp Med. 1990 May 1;171(5):1697-704 PMID: 2139699
  16. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
    Biochemistry. 1979 Nov 27;18(24):5294-9 PMID: 518835
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1990-12-00
Pages
10033-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC55309
Subset
IM
Grants
NIAID NIH HHS · 1P01AI28046 · United States
NIA NIH HHS · AG05628 · United States
NIAID NIH HHS · AI23360 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com